Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II)
Clinical trial NCT06760273 · RECRUITING
Trial details
- NCT number
- NCT06760273
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-10-16
- Primary completion
- 2027-12-31
- Enrollment
- 364
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.